Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2000
03/16/2000CA2342769A1 Drug preparations for treating sexual dysfunction
03/16/2000CA2342625A1 Lipstatin derivative-soluble fiber tablets
03/16/2000CA2341643A1 Plaster containing a medicament, with three functional layers
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2308472A1 Ophthalmic compositions and process of using
03/16/2000CA2306165A1 Composition for improving mental capabilities in mammals
03/15/2000EP0986164A1 Brush holder
03/15/2000EP0985413A1 Medical articles with sustained pharmacological activity and process for their preparation
03/15/2000EP0985412A2 Cyclosporin compositions
03/15/2000EP0985411A1 Sterol esters in tableted solid dosage forms
03/15/2000EP0984925A1 Compounds, preparation and use for transferring nucleic acids into cells
03/15/2000EP0984798A2 Drug delivery via therapeutic hydrogels
03/15/2000EP0984785A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
03/15/2000EP0984781A1 Analgesic drug composition containing a capsaicinoid and potentiator therefor
03/15/2000EP0984775A1 Selectively-activatible sheet material for dispensing and dispersing a substance onto a target surface
03/15/2000EP0984774A1 Gastroretentive controlled release microspheres for improved drug delivery
03/15/2000EP0984773A1 Pharmaceutical formulation of omeprazole
03/15/2000EP0984772A1 Composition comprising a liquid absorbed on a support based on precipitate silica
03/15/2000EP0984771A1 Stabilized gas-supersaturated emulsions and suspensions
03/15/2000EP0984762A1 Flow controller configurations for an active agent delivery device
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0859606A4 Buccal delivery of glucagon-like insulinotropic peptides
03/15/2000EP0814780A4 Diltiazem controlled release formulation
03/15/2000EP0806943B1 Valaciclovir tablets containing colloidal silicon dioxide
03/15/2000EP0729756B1 Granular preparation
03/15/2000EP0667767B1 Method for the preparation of creams
03/15/2000EP0655900B1 Foam laminate transdermal patch
03/15/2000EP0506785B1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
03/15/2000CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
03/15/2000CN1247471A Oxacarbazepine filme-coated tablets
03/15/2000CN1247468A Dermatological patch sheet and process for producing base sheet therefor
03/15/2000CN1247467A Agent for producing long-lasting saturation effect
03/15/2000CN1247197A Application of copolymer including N-vinyl pyrrolidone and vinyl acetate
03/15/2000CN1247092A Activated medical water and its preparing process and usage
03/15/2000CN1247091A Freeze-dired attenuated live vaccine for hepatitis A and its preparing process
03/15/2000CN1247080A Enteric coated particles and its preparing process
03/15/2000CN1247079A Immersed-in-wine Chinese medicine for preventing and curing AIDS
03/15/2000CN1247078A Process for preparing medical particles Qingkailing by wrapping chololic acid and animal extract with cyclodextrin
03/15/2000CN1247076A Medical capsules for treating asthma
03/15/2000CN1247074A Medical capsules for treating arthritides and its preparing process
03/15/2000CN1247060A Novel medicinal compsns. containing cyclosporin
03/15/2000CN1050365C Method for prepn. of hexan-2-olefin pyranoseoside of alcohol and phenol
03/15/2000CN1050301C Implant compsns. containing biologically active protein, peptide or polypeptide
03/15/2000CN1050297C Chinese herbal medicine compsn. for preparing non-dependence anti-cancer pain-alleviating drug and prepn. thereof
03/15/2000CN1050296C External-use medicine for treatment of acne
03/15/2000CN1050295C Ginseng and royal jelly chewing tablets and preparation thereof
03/15/2000CN1050285C Method for prepn. of pressurised aerosol compositions
03/15/2000CN1050283C Gel-type cosmetic composite
03/14/2000US6037481 Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
03/14/2000US6037386 Latex barrier having polymer matrix comprising zinc oxide or zinc gluconate gel irritant deactivating agent; condoms, gloves
03/14/2000US6037360 Side effect reduction; treating sexual disorders
03/14/2000US6037346 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
03/14/2000US6037338 And reducing risk of heart attacks
03/14/2000US6037332 Method of urinary bladder instillation
03/14/2000US6037328 Ophthalmic solution containing ethoxylated glucose derivative, tyloxapol, polyoxyethylene-polyoxypropylene nonionic surfactant, tonicity agent, buffer
03/14/2000US6037323 Peptides and peptide analogues that mimic the structural and pharmacological properties of human apoa-i; treating disorders associated with dyslipoproteinemia, including hypercholesterolemia, cardiovascular disease, atherosclerosis,
03/14/2000US6036978 Antiinflammatory agents for gastrointestinal disorders
03/14/2000US6036977 Drug preparations for treating sexual dysfunction
03/14/2000US6036976 Sustained release microspheres and preparation thereof
03/14/2000US6036975 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
03/14/2000US6036974 Method and apparatus for preparation of molded tablet and thereby prepared molded tablet
03/14/2000US6036973 Therapy for neurological diseases
03/14/2000US6036968 Composition in the form of a smooth paste and process for its preparation
03/14/2000US6036948 Polyaspartamide derivatives as adsordents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals
03/14/2000US6036945 Delivery systems for active ingredients including sunscreen actives and methods of making same
03/14/2000US6036943 Methods for treating a person's teeth using sticky dental compositions in combination with passive-type dental trays
03/14/2000US6036942 Seal configuration for aerosol canister
03/14/2000US6036887 Storage stability, nonhydrolyzing; foods, cosmetics, paints
03/14/2000US6036644 Enhanced methods of ultrasound imaging using multiple frequencies
03/14/2000US6036126 Apparatus for separating particles of cohesive material according to size and process
03/14/2000CA2013188C Preservative system for ophthalmic formulations
03/14/2000CA2006105C Method for the treatment of periodontal disease by sustained delivery of a pharmaceutical agent to the crevicular pocket, composition of matter therefor and apparatus for the administration thereof
03/09/2000WO2000013029A1 Method for evaluating lipid a analog-containing injections
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012619A1 Dextran-maleic acid monoesters and hydrogels based thereon
03/09/2000WO2000012590A1 Method for the production of spherical microparticles consisting totally or partly of at least one water-insoluble polyglucan containing branches and microparticles produced according to said method
03/09/2000WO2000012588A1 Urethane(meth)acrylates containing siloxane groups and able to undergo free-radical polymerisation
03/09/2000WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000WO2000012454A1 Novel polycationic lipids
03/09/2000WO2000012175A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
03/09/2000WO2000012172A1 Controlled dosage drug delivery system
03/09/2000WO2000012170A1 Gelatinous body protection article having a therapeutic additive
03/09/2000WO2000012146A1 Gels and multilayer surface structures from boronic acid containing polymers
03/09/2000WO2000012137A1 Preserved cyclodextrin-containing compositions
03/09/2000WO2000012136A1 Powdery pernasal compositions
03/09/2000WO2000012135A1 Medicinal compositions with relieved bitterness, etc.
03/09/2000WO2000012127A2 Dna cancer vaccine and methods for its use
03/09/2000WO2000012125A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
03/09/2000WO2000012124A1 Oral vaccine compositions
03/09/2000WO2000012116A1 Method for administering insulinotropic peptides
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012100A1 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/09/2000WO2000012098A1 Medicinal compositions for treating eye diseases
03/09/2000WO2000012097A1 Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug
03/09/2000WO2000012081A1 Method and composition for delivering zinc to the nasal membrane
03/09/2000WO2000012072A2 The use of fumaric acid derivatives in transplant medicine
03/09/2000WO2000012070A1 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
03/09/2000WO2000012069A1 Therapeutic formulation for administering tolterodine with controlled release
03/09/2000WO2000012068A1 Method for producing solid dosing forms
03/09/2000WO2000012066A1 Alginate capsules for use in the treatment of brain tumour
1 ... 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 ... 2991